The ins and outs of pertussis toxin

Pertussis toxin, produced and secreted by the whooping cough agent Bordetella pertussis, is one of the most complex soluble bacterial proteins. It is actively secreted through the B. pertussis cell envelope by the Ptl secretion system, a member of the widespread type IV secretion systems. The toxin is composed of five subunits (named S1 to S5 according to their decreasing molecular weights) arranged in an A–B structure. The A protomer is composed of the enzymatically active S1 subunit, which catalyzes ADP‐ribosylation of the α subunit of trimeric G proteins, thereby disturbing the metabolic functions of the target cells, leading to a variety of biological activities. The B oligomer is composed of 1S2:1S3:2S4:1S5 and is responsible for binding of the toxin to the target cell receptors and for intracellular trafficking via receptor‐mediated endocytosis and retrograde transport. The toxin is one of the most important virulence factors of B. pertussis and is a component of all current vaccines against whooping cough.

[1]  T. Forsthuber,et al.  Pertussis Toxin Modulates the Immune Response to Neuroantigens Injected in Incomplete Freund’s Adjuvant: Induction of Th1 Cells and Experimental Autoimmune Encephalomyelitis in the Presence of High Frequencies of Th2 Cells1 , 2002, The Journal of Immunology.

[2]  Gabriel Waksman,et al.  Structure of the outer membrane complex of a type IV secretion system , 2009, Nature.

[3]  E Lanka,et al.  Conjugative Pili of IncP Plasmids, and the Ti Plasmid T Pilus Are Composed of Cyclic Subunits* , 1999, The Journal of Biological Chemistry.

[4]  G. Waksman,et al.  NMR structure of a complex between the VirB9/VirB7 interaction domains of the pKM101 type IV secretion system , 2007, Proceedings of the National Academy of Sciences.

[5]  F. Mooi,et al.  Role of Bordetella pertussis Virulence Factors in Adherence to Epithelial Cell Lines Derived from the Human Respiratory Tract , 1999, Infection and Immunity.

[6]  C. Locht,et al.  Long-term immunity against pertussis induced by a single nasal administration of live attenuated B. pertussis BPZE1. , 2010, Vaccine.

[7]  L. Nencioni,et al.  Mutants of pertussis toxin suitable for vaccine development. , 1989, Science.

[8]  P. Zambryski,et al.  Peptide linkage mapping of the Agrobacterium tumefaciens vir-encoded type IV secretion system reveals protein subassemblies , 2002, Proceedings of the National Academy of Sciences of the United States of America.

[9]  G. Waksman,et al.  Biochemical Dissection of the ATPase TraB, the VirB4 Homologue of the Escherichia coli pKM101 Conjugation Machinery , 2010, Journal of bacteriology.

[10]  P. Gounon,et al.  Testing the ‘+2 rule’ for lipoprotein sorting in the Escherichia coli cell envelope with a new genetic selection , 1999, Molecular microbiology.

[11]  N. Carbonetti,et al.  Expression, activity and cytotoxicity of pertussis toxin S1 subunit in transfected mammalian cells , 2001, Cellular microbiology.

[12]  Mark A. Miller,et al.  The rise in pertussis cases urges replacement of chemically-inactivated with genetically-inactivated toxoid for DTP. , 2007, Vaccine.

[13]  D. Burns,et al.  Type IV transporters of pathogenic bacteria. , 2003, Current opinion in microbiology.

[14]  E. Nester,et al.  Agrobacterium type IV secretion is a two‐step process in which export substrates associate with the virulence protein VirJ in the periplasm , 2002, Molecular microbiology.

[15]  R. Schneerson,et al.  Immunologic and epidemiologic experience of vaccination with a monocomponent pertussis toxoid vaccine. , 2001, Pediatrics.

[16]  K. Shirasu,et al.  The product of the virB4 gene of Agrobacterium tumefaciens promotes accumulation of VirB3 protein , 1994, Journal of bacteriology.

[17]  P. Ibsen.  The effect of formaldehyde, hydrogen peroxide and genetic detoxification of pertussis toxin on epitope recognition by murine monoclonal antibodies. , 1996, Vaccine.

[18]  R. Rappuoli,et al.  Bordetella parapertussis and Bordetella bronchiseptica contain transcriptionally silent pertussis toxin genes , 1987, Journal of bacteriology.

[19]  D. Burns,et al.  Binding of pertussis toxin to lipid vesicles containing glycolipids , 1993, Infection and immunity.

[20]  C. Locht,et al.  Roles of the disulfide bond and the carboxy-terminal region of the S1 subunit in the assembly and biosynthesis of pertussis toxin , 1990, Infection and immunity.

[21]  M. Pittman.  Pertussis toxin: the cause of the harmful effects and prolonged immunity of whooping cough. A hypothesis. , 1979, Reviews of infectious diseases.

[22]  C. Locht,et al.  A proposed mechanism of ADP-ribosylation catalyzed by the pertussis toxin S1 subunit. , 1995, Biochimie.

[23]  C. Locht,et al.  Role of ADP-Ribosyltransferase Activity of Pertussis Toxin in Toxin-Adhesin Redundancy with Filamentous Hemagglutinin duringBordetella pertussis Infection , 2001, Infection and Immunity.

[24]  M. Schmidt,et al.  Endocytosis and retrograde transport of pertussis toxin to the Golgi complex as a prerequisite for cellular intoxication. , 1997, European journal of cell biology.

[25]  R. Daynes,et al.  Inhibition of lymphocyte and neutrophil chemotaxis by pertussis toxin. , 1985, Journal of immunology.

[26]  J. Sarwar,et al.  Identification of Peptides That Mimic the Pertussis Toxin Binding Site on Bovine Fetuin , 2003, Applied and Environmental Microbiology.

[27]  J. Barbieri,et al.  Role of histidine 35 of the S1 subunit of pertussis toxin in the ADP-ribosylation of transducin. , 1994, The Journal of biological chemistry.

[28]  D. Burns,et al.  Evidence for a Ninth Gene, ptlI, in the Locus Encoding the Pertussis Toxin Secretion System of Bordetella pertussis and Formation of a PtlI-PtlF Complex* , 1996, The Journal of Biological Chemistry.

[29]  Interaction of pertussis toxin with cells and model membranes. , 1992, The Journal of biological chemistry.

[30]  R. Read,et al.  Crystal structure of the pertussis toxin-ATP complex: a molecular sensor. , 1996, Journal of molecular biology.

[31]  M. Schmidt,et al.  Identification of binding proteins for pertussis toxin on pancreatic beta cell-derived insulin-secreting cells. , 1995, Microbial pathogenesis.

[32]  R. Gupta,et al.  Glutaraldehyde inactivated pertussis vaccine: a less histamine sensitizing vaccine. , 1987, Journal of biological standardization.

[33]  E. Tuomanen,et al.  Characterization of two adhesins of Bordetella pertussis for human ciliated respiratory-epithelial cells. , 1985, The Journal of infectious diseases.

[34]  B. Meade,et al.  Pertussis toxin. Affinity purification of a new ADP-ribosyltransferase. , 1983, The Journal of biological chemistry.

[35]  Role of tryptophan 26 in the NAD glycohydrolase reaction of the S-1 subunit of pertussis toxin. , 1989, The Journal of biological chemistry.

[36]  G. Koraimann,et al.  Peptidoglycan degradation by specialized lytic transglycosylases associated with type III and type IV secretion systems. , 2005, Microbiology.

[37]  Xue-Rong Zhou,et al.  Dimerization of the Agrobacterium tumefaciens VirB4 ATPase and the effect of ATP‐binding cassette mutations on the assembly and function of the T‐DNA transporter , 1999, Molecular microbiology.

[38]  C. Locht,et al.  Nucleotide sequence homology to pertussis toxin gene in Bordetella bronchiseptica and Bordetella parapertussis , 1987, Infection and immunity.

[39]  M. Bukrinsky,et al.  The B-Oligomer of Pertussis Toxin Deactivates Cc Chemokine Receptor 5 and Blocks Entry of M-Tropic HIV-1 Strains , 1999, The Journal of experimental medicine.

[40]  Stabilization of the Pertussis Toxin Secretion Apparatus by the C Terminus of PtlD , 2008, Journal of bacteriology.

[41]  R. Read,et al.  Structure of a pertussis toxin–sugar complex as a model for receptor binding , 1994, Nature Structural Biology.

[42]  R. Rappuoli,et al.  Properties of the B oligomer of pertussis toxin , 1991, Infection and immunity.

[43]  A. Weiss,et al.  DsbA and DsbC Are Required for Secretion of Pertussis Toxin by Bordetella pertussis , 2002, Infection and Immunity.

[44]  J. Barbieri,et al.  Pertussis toxin-catalyzed ADP-ribosylation of Gi-2 and Gi-3 in CHO cells is modulated by inhibitors of intracellular trafficking , 1996, Infection and immunity.

[45]  Amy A. Rambow-Larsen,et al.  Temporal Expression of Pertussis Toxin and Ptl Secretion Proteins by Bordetella pertussis , 2004, Journal of bacteriology.

[46]  Mutants in the ptlA-H genes of Bordetella pertussis are deficient for pertussis toxin secretion. , 1999, FEMS microbiology letters.

[47]  Y. Sato,et al.  Leukocytosis-Promoting Factor of Bordetella pertussis III. Its Identity with Protective Antigen , 1974, Infection and immunity.

[48]  K. Shirasu,et al.  Membrane location of the Ti plasmid VirB proteins involved in the biosynthesis of a pilin-like conjugative structure on Agrobacterium tumefaciens. , 1993, FEMS microbiology letters.

[49]  C. Locht,et al.  Photolabelling of mutant forms of the S1 subunit of pertussis toxin with NAD+. , 1990, The Biochemical journal.

[50]  C. Locht,et al.  Live Attenuated B. pertussis as a Single-Dose Nasal Vaccine against Whooping Cough , 2006, PLoS pathogens.

[51]  C. Kado,et al.  Processed VirB2 Is the Major Subunit of the Promiscuous Pilus of Agrobacterium tumefaciens , 1998, Journal of bacteriology.

[52]  Xin Chen,et al.  Pertussis Toxin by Inducing IL-6 Promotes the Generation of IL-17-Producing CD4 Cells1 , 2007, The Journal of Immunology.

[53]  W. Miller,et al.  Pertussis Toxin Signals through the TCR to Initiate Cross-Desensitization of the Chemokine Receptor CXCR41 , 2009, The Journal of Immunology.

[54]  H. Sato,et al.  Experience with diphtheria toxoid-tetanus toxoid-acellular pertussis vaccine in Japan. , 1999, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[55]  Christoph Dehio,et al.  Bacterial type IV secretion systems in human disease , 2009, Molecular microbiology.

[56]  S. Savvides,et al.  VirB11 ATPases are dynamic hexameric assemblies: new insights into bacterial type IV secretion , 2003, The EMBO journal.

[57]  Use of glycosyltransferases to restore pertussis toxin receptor activity to asialoagalactofetuin. , 1988, The Journal of biological chemistry.

[58]  E. Cascales,et al.  Agrobacterium VirB10, an ATP energy sensor required for type IV secretion. , 2004, Proceedings of the National Academy of Sciences of the United States of America.

[59]  S. Hapfelmeier,et al.  VirB6 Is Required for Stabilization of VirB5 and VirB3 and Formation of VirB7 Homodimers in Agrobacterium tumefaciens , 2000, Journal of bacteriology.

[60]  S. Iyer,et al.  Identification and characterization of the carbohydrate ligands recognized by pertussis toxin via a glycan microarray and surface plasmon resonance. , 2010, Biochemistry.

[61]  P. Christie,et al.  Agrobacterium tumefaciens VirB6 Protein Participates in Formation of VirB7 and VirB9 Complexes Required for Type IV Secretion , 2003, Journal of bacteriology.

[62]  N. Carbonetti,et al.  Pertussis Toxin Stimulates IL-17 Production in Response to Bordetella pertussis Infection in Mice , 2009, PloS one.

[63]  Shizuo Akira,et al.  Toll-like Receptor Signaling* , 2003, Journal of Biological Chemistry.

[64]  Yue Sun,et al.  Pertussis Toxin Enhances Th1 Responses by Stimulation of Dendritic Cells 1 , 2003, The Journal of Immunology.

[65]  E. Hewlett,et al.  Identification of the predominant substrate for ADP-ribosylation by islet activating protein. , 1983, The Journal of biological chemistry.

[66]  D. Burns,et al.  Membrane Localization of the S1 Subunit of Pertussis Toxin in Bordetella pertussis and Implications for Pertussis Toxin Secretion , 2002, Infection and Immunity.

[67]  Thomas F Meyer,et al.  Type IV secretion systems and their effectors in bacterial pathogenesis. , 2006, Current opinion in microbiology.

[68]  Paul B. Mann,et al.  The Complex Mechanism of Antibody-Mediated Clearance of Bordetella from the Lungs Requires TLR41 , 2005, The Journal of Immunology.

[69]  J. Ortaldo,et al.  Pertussis toxin as an adjuvant suppresses the number and function of CD4+CD25+ T regulatory cells , 2006, European journal of immunology.

[70]  N. Carbonetti,et al.  Pertussis Toxin Inhibits Early Chemokine Production To Delay Neutrophil Recruitment in Response to Bordetella pertussis Respiratory Tract Infection in Mice , 2008, Infection and Immunity.

[71]  R. Rappuoli,et al.  Pertussis toxin potentiates Th1 and Th2 responses to co-injected antigen: adjuvant action is associated with enhanced regulatory cytokine production and expression of the co-stimulatory molecules B7-1, B7-2 and CD28. , 1998, International immunology.

[72]  E. Hewlett,et al.  Amino acid-specific ADP-ribosylation. Sensitivity to hydroxylamine of [cysteine(ADP-ribose)]protein and [arginine(ADP-ribose)]protein linkages. , 1985, The Journal of biological chemistry.

[73]  A. Murzin,et al.  Aerolysin and pertussis toxin share a common receptor‐binding domain , 1997, The EMBO journal.

[74]  S. Cockle,et al.  Characterization of pertussis toxin analogs containing mutations in B-oligomer subunits , 1993, Infection and immunity.

[75]  T. Katada,et al.  ADP ribosylation of the specific membrane protein of C6 cells by islet-activating protein associated with modification of adenylate cyclase activity. , 1982, The Journal of biological chemistry.

[76]  P. Halushka,et al.  Toll-like receptor 4 coupled GI protein signaling pathways regulate extracellular signal-regulated kinase phosphorylation and AP-1 activation independent of NFkappaB activation. , 2004, Shock.

[77]  V. Schramm,et al.  Pertussis toxin: transition state analysis for ADP-ribosylation of G-protein peptide alphai3C20. , 1997, Biochemistry.

[78]  R. Rappuoli,et al.  Cloning and sequencing of the pertussis toxin genes: operon structure and gene duplication. , 1986, Proceedings of the National Academy of Sciences of the United States of America.

[79]  L. Birnbaumer,et al.  Peptide inhibitors of ADP-ribosylation by pertussis toxin are substrates with affinities comparable to those of the trimeric GTP-binding proteins. , 1992, Molecular pharmacology.

[80]  B. Mahon,et al.  A Live, Attenuated Bordetella pertussis Vaccine Provides Long-Term Protection against Virulent Challenge in a Murine Model , 2010, Clinical and Vaccine Immunology.

[81]  D. Burns,et al.  Detection and subcellular localization of three Ptl proteins involved in the secretion of pertussis toxin from Bordetella pertussis , 1994, Journal of bacteriology.

[82]  R. Read,et al.  Accumulating evidence suggests that several AB-toxins subvert the endoplasmic reticulum-associated protein degradation pathway to enter target cells. , 1997, Biochemistry.

[83]  H. C. Wu,et al.  Lipid modification of bacterial prolipoprotein. Transfer of diacylglyceryl moiety from phosphatidylglycerol. , 1994, The Journal of biological chemistry.

[84]  B. Arulanandam,et al.  Induction of polyclonal CD8+ T cell activation and effector function by Pertussis toxin. , 2011, Cellular immunology.

[85]  W. N. Burnette,et al.  Pertussis toxin S1 mutant with reduced enzyme activity and a conserved protective epitope. , 1988, Science.

[86]  N. Carbonetti,et al.  Retrograde transport of pertussis toxin in the mammalian cell , 2008, Cellular microbiology.

[87]  R. Rappuoli,et al.  Genetically Detoxified Pertussis Toxin Induces Th1/Th17 Immune Response through MAPKs and IL-10-Dependent Mechanisms1 , 2009, The Journal of Immunology.

[88]  E. Tuomanen,et al.  Filamentous hemagglutinin and pertussis toxin promote adherence of Bordetella pertussis to cilia. , 1985, Developments in biological standardization.

[89]  Mutations in the S1 Subunit of Pertussis Toxin That Affect Secretion , 2000, Infection and Immunity.

[90]  T. Katada,et al.  Subunit structure of islet-activating protein, pertussis toxin, in conformity with the A-B model. , 1982, Biochemistry.

[91]  E. Hewlett,et al.  Activation by thiol of the latent NAD glycohydrolase and ADP-ribosyltransferase activities of Bordetella pertussis toxin (islet-activating protein). , 1983, The Journal of biological chemistry.

[92]  A. Das,et al.  Agrobacterium tumefaciens Type IV Secretion Protein VirB3 Is an Inner Membrane Protein and Requires VirB4, VirB7, and VirB8 for Stabilization , 2010, Journal of bacteriology.

[93]  C. Locht,et al.  Intracellular trafficking and membrane translocation of pertussis toxin into host cells. , 2000, International journal of medical microbiology : IJMM.

[94]  C. Locht,et al.  Genetic exchange of the S2 and S3 subunits in pertussis toxin , 2006, Molecular microbiology.

[95]  S. Tatulian,et al.  The pertussis toxin S1 subunit is a thermally unstable protein susceptible to degradation by the 20S proteasome. , 2006, Biochemistry.

[96]  C. Kado,et al.  Biogenesis of T Pili in Agrobacterium tumefaciens Requires Precise VirB2 Propilin Cleavage and Cyclization , 2002, Journal of bacteriology.

[97]  F. D. Johnson,et al.  Molecular characterization of an operon required for pertussis toxin secretion. , 1993, Proceedings of the National Academy of Sciences of the United States of America.

[98]  C. Locht,et al.  Pertussis toxin gene: nucleotide sequence and genetic organization. , 1986, Science.

[99]  C. Locht,et al.  T- and B-Cell-Mediated Protection Induced by Novel, Live Attenuated Pertussis Vaccine in Mice. Cross Protection against Parapertussis , 2010, PloS one.

[100]  W. N. Burnette,et al.  Pertussis toxin has eukaryotic-like carbohydrate recognition domains. , 1992, Proceedings of the National Academy of Sciences of the United States of America.

[101]  D. Burns,et al.  Adenine nucleotides promote dissociation of pertussis toxin subunits. , 1986, The Journal of biological chemistry.

[102]  R. Read,et al.  The crystal structure of pertussis toxin. , 1994, Structure.

[103]  D. Burns,et al.  Essential role of the consensus nucleotide-binding site of PtlH in secretion of pertussis toxin from Bordetella pertussis , 1997, Journal of bacteriology.

[104]  C. Locht,et al.  Evidence for a catalytic role of glutamic acid 129 in the NAD-glycohydrolase activity of the pertussis toxin S1 subunit. , 1993, The Journal of biological chemistry.

[105]  J. Munoz,et al.  ANTIGENS OF BORDETELLA PERTUSSIS II , 1962, Journal of bacteriology.

[106]  C. Locht,et al.  Identification of amino acid residues essential for the enzymatic activities of pertussis toxin. , 1989, Proceedings of the National Academy of Sciences of the United States of America.

[107]  C. Baron,et al.  The VirB5 protein localizes to the T-pilus tips in Agrobacterium tumefaciens. , 2007, Microbiology.

[108]  G. Waksman,et al.  Structural insights into the membrane-extracted dimeric form of the ATPase TraB from the Escherichia coli pKM101 conjugation system , 2011, BMC Structural Biology.

[109]  B. Beutler,et al.  The interface between innate and adaptive immunity , 2004, Nature Immunology.

[110]  C. Locht,et al.  The role of cysteine 41 in the enzymatic activities of the pertussis toxin S1 subunit as investigated by site-directed mutagenesis. , 1990, The Journal of biological chemistry.

[111]  C. Locht,et al.  Homologous and heterologous protection after single intranasal administration of live attenuated recombinant Bordetella pertussis , 1998, Nature Biotechnology.

[112]  E. Lanka,et al.  A specific protease encoded by the conjugative DNA transfer systems of IncP and Ti plasmids is essential for pilus synthesis , 1997, Journal of bacteriology.

[113]  R. Gold,et al.  The PLPp-specific T-cell population promoted by pertussis toxin is characterized by high frequencies of IL-17-producing cells. , 2007, Cytokine.

[114]  C. Locht,et al.  Site-specific alterations in the B oligomer that affect receptor- binding activities and mitogenicity of pertussis toxin , 1993, The Journal of experimental medicine.

[115]  M. Brennan,et al.  Lectin-like binding of pertussis toxin to a 165-kilodalton Chinese hamster ovary cell glycoprotein. , 1988, The Journal of biological chemistry.

[116]  N. Carbonetti,et al.  Pertussis Toxin Plays an Early Role in Respiratory Tract Colonization by Bordetella pertussis , 2003, Infection and Immunity.

[117]  S. Su,et al.  Induction of dendritic cell maturation by pertussis toxin and its B subunit differentially initiate Toll-like receptor 4-dependent signal transduction pathways. , 2006, Experimental hematology.

[118]  A. Verma,et al.  Analysis of Subassemblies of Pertussis Toxin Subunits In Vivo and Their Interaction with the Ptl Transport Apparatus , 2004, Infection and Immunity.

[119]  V. Schramm,et al.  Kinetic isotope effect characterization of the transition state for oxidized nicotinamide adenine dinucleotide hydrolysis by pertussis toxin. , 1997, Biochemistry.

[120]  Johannes Tramper,et al.  Effect of relevant culture parameters on Pertussis Toxin expression by Bordetella pertussis. , 2006, Biologicals : journal of the International Association of Biological Standardization.

[121]  A. Weiss,et al.  Reduced Glutathione Is Required for Pertussis Toxin Secretion by Bordetella pertussis , 2003, Infection and Immunity.

[122]  O. Bjørnstad,et al.  Pertussis toxin inhibits neutrophil recruitment to delay antibody-mediated clearance of Bordetella pertussis. , 2005, The Journal of clinical investigation.

[123]  E. Hewlett,et al.  Role of pertussis toxin A subunit in neutrophil migration and vascular permeability , 1997, Infection and immunity.

[124]  S. Cockle.  Identification of an active‐site residue in subunit S1 of pertussis toxin by photocrosslinking to NAD , 1989, FEBS letters.

[125]  R. Tuskan,et al.  Pertussis toxin and the adenylate cyclase toxin from Bordetella pertussis activate human monocyte‐derived dendritic cells and dominantly inhibit cytokine production through a cAMP‐dependent pathway , 2002, Journal of leukocyte biology.

[126]  S. Savvides,et al.  Crystal structure of the hexameric traffic ATPase of the Helicobacter pylori type IV secretion system. , 2000, Molecular cell.

[127]  Importance of Holotoxin Assembly in Ptl-Mediated Secretion of Pertussis Toxin from Bordetella pertussis , 2000, Infection and Immunity.

[128]  Identification and Characterization of PtlC, an Essential Component of the Pertussis Toxin Secretion System , 1999, Infection and Immunity.

[129]  D. Burns,et al.  Biochemistry of type IV secretion. , 1999, Current opinion in microbiology.

[130]  H. Sato,et al.  Effect of heptakis (2,6-O-dimethyl) beta-cyclodextrin on the production of pertussis toxin by Bordetella pertussis , 1983, Infection and immunity.

[131]  W. N. Burnette,et al.  Properties of pertussis toxin B oligomer assembled in vitro from recombinant polypeptides produced by Escherichia coli , 1992, Infection and immunity.

[132]  R. Liblau,et al.  Pertussis Toxin Reduces the Number of Splenic Foxp3+ Regulatory T Cells1 , 2006, The Journal of Immunology.

[133]  Amy A. Rambow-Larsen,et al.  The PtlE Protein of Bordetella pertussis Has Peptidoglycanase Activity Required for Ptl-Mediated Pertussis Toxin Secretion , 2002, Journal of bacteriology.

[134]  M. Denkinger,et al.  Pertussis toxin-induced cytokine differentiation and clonal expansion of T cells is mediated predominantly via costimulation. , 2007, Cellular immunology.

[135]  W. Sewell,et al.  Regulation of DTH and IgE responses by IL-4 and IFN-gamma in immunized mice given pertussis toxin. , 1994, Immunology.

[136]  E. Orlova,et al.  Structure of a Type IV Secretion System Core Complex , 2009, Science.

[137]  G. Koraimann,et al.  Functional and Mutational Analysis of P19, a DNA Transfer Protein with Muramidase Activity , 2001, Journal of bacteriology.

[138]  P. Halushka,et al.  TOLL-LIKE RECEPTOR 4 COUPLED GI PROTEIN SIGNALING PATHWAYS REGULATE EXTRACELLULAR SIGNAL-REGULATED KINASE PHOSPHORYLATION AND AP-1 ACTIVATION INDEPENDENT OF NFκB ACTIVATION , 2004 .

[139]  C. Locht,et al.  Dose Response of Attenuated Bordetella pertussis BPZE1-Induced Protection in Mice , 2010, Clinical and Vaccine Immunology.

[140]  R. Macnab,et al.  Peptidoglycan-Hydrolyzing Activity of the FlgJ Protein, Essential for Flagellar Rod Formation inSalmonella typhimurium , 1999, Journal of bacteriology.

[141]  A. Helenius,et al.  Role of ATP and disulphide bonds during protein folding in the endoplasmic reticulum , 1992, Nature.

[142]  J. Barbieri,et al.  Pertussis toxin-mediated ADP-ribosylation of target proteins in Chinese hamster ovary cells involves a vesicle trafficking mechanism , 1995, Infection and immunity.

[143]  A. Verma,et al.  Requirements for Assembly of PtlH with the Pertussis Toxin Transporter Apparatus of Bordetella pertussis , 2007, Infection and Immunity.

[144]  Johannes Tramper,et al.  Fed-batch cultivation of Bordetella pertussis: metabolism and Pertussis Toxin production. , 2006, Biologicals : journal of the International Association of Biological Standardization.

[145]  D Eisenberg,et al.  Crystal structure of diphtheria toxin bound to nicotinamide adenine dinucleotide. , 1996, Biochemistry.